In search of a depressed mouse: utility of models for studying depression-related behavior in genetically modified mice
Top Cited Papers
- 13 January 2004
- journal article
- review article
- Published by Springer Nature in Molecular Psychiatry
- Vol. 9 (4) , 326-357
- https://doi.org/10.1038/sj.mp.4001457
Abstract
The ability to modify mice genetically has been one of the major breakthroughs in modern medical science affecting every discipline including psychiatry. It is hoped that the application of such technologies will result in the identification of novel targets for the treatment of diseases such as depression and to gain a better understanding of the molecular pathophysiological mechanisms that are regulated by current clinically effective antidepressant medications. The advent of these tools has resulted in the need to adopt, refine and develop mouse-specific models for analyses of depression-like behavior or behavioral patterns modulated by antidepressants. In this review, we will focus on the utility of current models (eg forced swim test, tail suspension test, olfactory bulbectomy, learned helplessness, chronic mild stress, drug-withdrawal-induced anhedonia) and research strategies aimed at investigating novel targets relevant to depression in the mouse. We will focus on key questions that are considered relevant for examining the utility of such models. Further, we describe other avenues of research that may give clues as to whether indeed a genetically modified animal has alterations relevant to clinical depression. We suggest that it is prudent and most appropriate to use convergent tests that draw on different antidepressant-related endophenotypes, and complimentary physiological analyses in order to provide a program of information concerning whether a given phenotype is functionally relevant to depression-related pathology.Keywords
This publication has 382 references indexed in Scilit:
- Reduced phosphorylation of cyclic AMP-responsive element binding protein in the postmortem orbitofrontal cortex of patients with major depressive disorderJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 2003
- Pharmacological effects of venlafaxine, a new antidepressant, given repeatedly, on the α 1 -adrenergic, dopamine and serotonin systemsJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1999
- Published by Springer Nature ,1998
- THE EFFECTS OF STRESSFUL LIFE EVENTS ON DEPRESSIONAnnual Review of Psychology, 1997
- ?-CIT SPECT demonstrates blockade of 5HT-uptake sites by citalopram in the human brain in vivoJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1995
- Autoradiographic distribution of cholinergic muscarinic receptors and serotonin2 receptors in olfactory bulbectomized (OB) rats after chronic treatment with mianserin and desipramineHuman Psychopharmacology: Clinical and Experimental, 1994
- Antidepressants suppress bulbectomy-induced augmentation of voluntary alcohol consumption in C57Bl/6j but not in DBA/2j micePhysiology & Behavior, 1994
- Amphetamine withdrawal: A behavioral evaluationLife Sciences, 1986
- Functional evidence for subsensitivity of noradrenergic α2 receptors after chronic desipramine treatmentLife Sciences, 1980
- Development of open‐field behavior in mice: Effects of age and experienceDevelopmental Psychobiology, 1968